Alshammari Hesah, Al-Saeed Eman, Ahmed Zamzam, Aslanpour Zoe
Department of Clinical and Pharmaceutical Sciences, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK.
Drug Healthc Patient Saf. 2021 Nov 3;13:183-210. doi: 10.2147/DHPS.S303101. eCollection 2021.
Potentially inappropriate medication (PIM) is a primary health concern affecting the quality of life of patients over 65. PIM is associated with adverse drug reactions including falls, increased healthcare costs, health services utilization and hospital admissions. Various strategies, clinical guidelines and tools (explicit and implicit) have been developed to tackle this health concern. Despite these efforts, evidence still indicates a high prevalence of PIM in the older adult population. This systematic review explored the practice of using explicit tools to review PIM in hospitalized patients and examined the outcomes of PIM reduction. A literature search was conducted in several databases from their inception to 2019. Original studies that had an interventional element using explicit criteria detecting PIM in hospitalized patients over 65 were included. Descriptive narrative synthesis was used to analyze the included studies. The literature search yielded 6116 articles; 25 quantitative studies were included in this systematic literature review. Twenty were prospective studies and five were retrospective. Approximately, 15,500 patients were included in the review. Various healthcare professionals were involved in reviewing PIM including physicians and hospital pharmacists. Several tools were used to review PIM for hospitalized patients over 65, most frequently Beer's criteria and the STOPP/START tool. The reduction of PIM ranged from 3.5% up to 87%. The most common PIM were benzodiazepines and antipsychotics. This systematic review showed promising outcomes in terms of improving patient outcomes. However, the reduction of PIM varied in the studies, raising the question of the variance between hospitals in the explicit tools used for review. Additional studies need to be conducted to further investigate the outcomes of reviewing PIM at different levels, as well as assessing the cost-effectiveness of using explicit tools in reducing PIM.
潜在不适当用药(PIM)是一个主要的健康问题,影响着65岁以上患者的生活质量。PIM与药物不良反应相关,包括跌倒、医疗费用增加、医疗服务利用和住院。为解决这一健康问题,已制定了各种策略、临床指南和工具(明确的和隐含的)。尽管做出了这些努力,但证据仍表明PIM在老年人群中普遍存在。本系统评价探讨了使用明确工具对住院患者进行PIM审查的实践,并检查了PIM减少的结果。从各数据库建立到2019年进行了文献检索。纳入了使用明确标准检测65岁以上住院患者PIM的具有干预因素的原始研究。采用描述性叙述性综合分析纳入的研究。文献检索共获得6116篇文章;本系统文献综述纳入了25项定量研究。其中20项为前瞻性研究,5项为回顾性研究。综述中约纳入了15500名患者。包括医生和医院药剂师在内的各种医疗专业人员参与了PIM审查。使用了几种工具对65岁以上住院患者进行PIM审查,最常用的是Beer标准和STOPP/START工具。PIM的减少幅度从3.5%到87%不等。最常见的PIM是苯二氮䓬类药物和抗精神病药物。本系统评价在改善患者结局方面显示出了有希望的结果。然而,不同研究中PIM的减少情况各不相同,这就引发了不同医院在用于审查的明确工具方面存在差异的问题。需要进行更多研究,以进一步调查不同层面审查PIM的结果,以及评估使用明确工具减少PIM的成本效益。